BBP / ETFis Series Trust I - Virtus Biotech ETF - Net Long/Short Value

ETFis Series Trust I - Virtus Biotech ETF
US ˙ ARCA ˙ US26923G2021

BBP / ETFis Series Trust I - Virtus Biotech ETF - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Cwm, Llc
Cetera Investment Advisers
Bessemer Group Inc
Fifth Third Bancorp
CWA Asset Management Group, LLC
UBS Group AG
Byrne Asset Management LLC
Raymond James Financial Inc
Two Sigma Investments, Lp
Citigroup Inc
Prime Capital Investment Advisors, LLC
Portus Wealth Advisors, LLC
Envestnet Asset Management Inc
Independent Financial Group, Llc
Glen Eagle Advisors, LLC
Susquehanna International Group, Llp
Fulcrum Equity Management
Allworth Financial LP
Morgan Stanley
Comerica Bank
LPL Financial LLC
Wbi Investments, Inc.
Sound Income Strategies, LLC
Advisor Resource Council
Royal Bank Of Canada
Jane Street Group, Llc
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista